Voyager Therapeutics(DE:VT6)
€1.46-0.04 (-2.79%)
DE:VT6
Voyager Therapeutics earnings date
€1.46
At close:-0.04 (-2.79%)
Voyager Therapeutics (VT6) Q4 2021 Earnings Report
5 Followers
DE:VT6 Q4 2021 EPS Results
- Actual EPS
- EUR 0.14
- Consensus EPS
- -EUR 0.56
- Beat/Miss
- Beat by +EUR 0.70
- One Year Ago EPS
- -EUR 0.39
DE:VT6 Q4 2021 Revenue Results
- Actual Revenue
- EUR 25.38M
- Expected Revenue
- EUR 3.88M
- Beat/Miss
- Beat by +EUR 21.49M
- YoY Revenue Growth
- +329.45%
Earnings Announcement Details
- Quarter
- Q4 2021
- Date
- 03/08/2022
- Time
- Before Open
- Conference Call
- Tuesday, March 8, 2022
DE:VT6 Upcoming Earnings
Voyager Therapeutics's next earnings date is estimated for March 9, 2027, based on past reporting schedules.
Q4 2021 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q4 2021 Earnings Slide Deck
No slide deck is available for this earnings event.
Q4 2021 Earnings Call Summary
No earnings call summary is available for this earnings event.
DE:VT6 Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 09, 2027 | 2026 (Q4) | -0.31- | -0.42 | ― | ― |
| Nov 05, 2026 | 2026 (Q3) | -0.38-0.36 | -0.42 | 14.89% (+0.06) | |
| Aug 06, 2026 | 2026 (Q2) | -0.44-0.36 | -0.52 | 29.82% (+0.15) | |
| May 07, 2026 | 2026 (Q1) | -0.50-0.42 | -0.48 | 11.32% (+0.05) | |
| Mar 09, 2026 | 2025 (Q4) | -0.46-0.42 | -0.53 | 22.03% (+0.12) | |
| Nov 10, 2025 | 2025 (Q3) | -0.47-0.42 | -0.14 | -193.75% (-0.28) | |
| Aug 06, 2025 | 2025 (Q2) | -0.48-0.52 | -0.16 | -216.67% (-0.35) | |
| May 06, 2025 | 2025 (Q1) | -0.41-0.48 | -0.18 | -165.00% (-0.30) | |
| Mar 11, 2025 | 2024 (Q4) | -0.33-0.53 | 1.13 | -147.20% (-1.66) | |
| Nov 12, 2024 | 2024 (Q3) | -0.40-0.14 | -0.53 | 72.88% (+0.39) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed

